Dr. Alan A. Brijbassie, MD

Dr. Brijbassie practices at Augusta Medical Group in Waynesboro, Virginia.

Dr. Brijbassie's NPI, 1992964704, was assigned on June 6, 2008. Dr. Brijbassie graduated from University of the West Indies Faculty of Medicine in 2003. Dr. Brijbassie holds Virginia license 0101251502.

Dr. Brijbassie's primary practice is Augusta Medical Group, at 201 Lew Dewitt Blvd, Waynesboro, VA 22980 in Waynesboro City. The practice phone is (540) 932-5162.

Dr. Brijbassie's primary practice is Augusta Medical Group in Waynesboro, Virginia. Dr. Brijbassie is also affiliated with University Medical Center. The medical group on file is Augusta Health. Dmand AI also links Dr. Brijbassie to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brijbassie practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Brijbassie's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Brijbassie is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Brijbassie is licensed in Virginia.

Dmand AI lists acid reflux, colonoscopy, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Brijbassie treats.

CMS data shows 455 Medicare services from Dr. Brijbassie across 19 procedure codes in 2024, for 268 Medicare patients. Medicare paid $47,404 for them.

CMS counts 268 Medicare patients who saw Dr. Brijbassie in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brijbassie's median patient age at 71, with 55% women.

In 2024, Dr. Brijbassie wrote 230 Medicare Part D claims for 69 patients. 94% of them were for generic drugs. CMS names the drug for 176 of them, across 6 drugs with 11 or more claims each, at $7,534 in total drug cost.

Dr. Brijbassie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 311 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Brijbassie, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Brijbassie, published from 2013 to 2016. 2013 was the busiest year, with 2. The most frequent topics are Stents. Dr. Brijbassie has published most often in Gastroenterology Res. Dr. Brijbassie's most frequent co-authors are Isaac L. Raijman, MD, David E. Loren, MD and Sandeep Natvarlal Patel, DO.

CMS Open Payments shows 25 general payments to Dr. Brijbassie from 11 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $198.

Dr. Brijbassie graduated from University of the West Indies Faculty of Medicine in 2003.

Dr. Brijbassie is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.